NCT06223828View on ClinicalTrials.gov

Azithromycin for Critical Asthma - Pediatrics

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pediatric AsthmaCritical Illness
Interventions
DRUG

Azithromycin

10mg/kg/dose (max dose 500mg) once daily for 3 days

Trial Locations (1)

33701

RECRUITING

Johns Hopkins All Children's Hospital, St. Petersburg

All Listed Sponsors
lead

Johns Hopkins All Children's Hospital

OTHER